Supporting investment into the region and companies to find funding opportunities

Open funding calls

Biomedical Catalyst 2019 round 1: feasibility and primer awards

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

Your project

Your project must start by 1 September 2019 and end by 31 March 2021. It can last between 3 and 18 months.

Your project’s total eligible costs must be between £50,000 and £1 million. If your project’s total eligible costs or duration fall outside of our eligibility criteria, you must provide justification by email to [email protected] at least 10 days before the competition closes. We will decide whether to approve your request.

Lead applicant

To lead a project or work alone you must:

  • be a UK based micro, small or medium-sized enterprise (SME) or a research and technology organisation (RTO)
  • be an organisation focused on life science
  • carry out your project in the UK

You can work alone or in partnership with others (SMEs, academics or research organisations).

If your project is academic-led you need to apply to the Medical Research Council instead.

Further information, and the application form, can be found here

Competition opens: Monday 21 January 2019
Competition deadline: Wednesday 3 April 12.00pm

Biomedical Catalyst 2019 round 1: early and late stage awards

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

The aim of this competition is to enable companies to create a data package that can support the subsequent testing of your products or carry out evaluations in a clinical setting or other relevant environment. This can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • demonstrating of clinical utility and effectiveness
  • demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge.

Further information, and the application form, can be found here

Competition opens: Monday 21 January 2019
Competition deadline: Wednesday 3 April 12.00pm

OxLEP Innovation Support for Business (ISfB) programme, Phase 2

ISfB Phase 2 is a £5.2m investment supporting Oxfordshire’s innovative entrepreneurs and small and medium sized enterprises (SMEs). We do this by assisting the development and commercialisation of innovative business ideas, as well as enhancing research and innovation infrastructure in Oxfordshire.

Through our latest ISfB programme, we also aim to promote business investment in research and innovation, as well as developing links between businesses and researchers.

We deliver the ISfB programme with partners from the University of OxfordCherwell District CouncilOxford City Council and Oxford University Hospitals NHS Foundation Trust and offer a customisable portfolio of help for eligible entrepreneurs, start-ups and businesses to encourage innovation.

Our support includes:

  • ‘Go-create’ grants
  • Coaching and mentoring
  • Workshops, seminars and master classes
  • Access to equipment, expertise and resources

To find out how we can support you to innovate email [email protected].

Contact: Ashley Aitken

Ashley Aitken
Senior Programme Manager

Ashley has experience of sales and marketing in the life science sector. She is a graduate of the University of Warwick, and specialised in Molecular Genetics.
Email Ashley

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu